242 related articles for article (PubMed ID: 29954402)
1. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma.
Hwang HM; Heo CK; Lee HJ; Kwak SS; Lim WH; Yoo JS; Yu DY; Lim KJ; Kim JY; Cho EW
J Transl Med; 2018 Jun; 16(1):177. PubMed ID: 29954402
[TBL] [Abstract][Full Text] [Related]
2. Cyclic Peptide Mimotopes for the Detection of Serum Anti-ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma.
Heo CK; Hwang HM; Lim WH; Lee HJ; Yoo JS; Lim KJ; Cho EW
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352757
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma.
Heo CK; Hwang HM; Lee HJ; Kwak SS; Yoo JS; Yu DY; Lim KJ; Lee S; Cho EW
Sci Rep; 2019 Jul; 9(1):11059. PubMed ID: 31363116
[TBL] [Abstract][Full Text] [Related]
4. Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC.
Heo CK; Woo MK; Yu DY; Lee JY; Yoo JS; Yoo HS; Ko JH; Kim JM; Choi JY; Kim IG; Paik SG; Cho EW
Int J Oncol; 2010 Jun; 36(6):1453-9. PubMed ID: 20428769
[TBL] [Abstract][Full Text] [Related]
5. Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA.
Heo CK; Lim WH; Park I; Choi YS; Lim KJ; Cho EW
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36321789
[TBL] [Abstract][Full Text] [Related]
6. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
[TBL] [Abstract][Full Text] [Related]
7. Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Shen Y; Chen J; Wu J; Li T; Yi C; Wang K; Wang P; Sun C; Ye H
Cancer Prev Res (Phila); 2024 May; 17(5):227-235. PubMed ID: 38489403
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
[TBL] [Abstract][Full Text] [Related]
9. Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing AFP-negative hepatocellular carcinoma.
Li Q; Liu H; Wang H; Xiong W; Dai L; Zhang X; Wang P; Ye H; Shi J; Fang Z; Wang K
PeerJ; 2024; 12():e17494. PubMed ID: 38832035
[TBL] [Abstract][Full Text] [Related]
10. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
Welberry C; Macdonald I; McElveen J; Parsy-Kowalska C; Allen J; Healey G; Irving W; Murray A; Chapman C
PLoS One; 2020; 15(5):e0232247. PubMed ID: 32374744
[TBL] [Abstract][Full Text] [Related]
12. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
[TBL] [Abstract][Full Text] [Related]
13. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
[TBL] [Abstract][Full Text] [Related]
14. Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma.
Son JA; Weon JH; Baek GO; Ahn HR; Choi JY; Yoon MG; Cho HJ; Cheong JY; Eun JW; Kim SS
J Exp Clin Cancer Res; 2023 Oct; 42(1):288. PubMed ID: 37899451
[TBL] [Abstract][Full Text] [Related]
15. Serum autoantibody measurement for the detection of hepatocellular carcinoma.
Middleton CH; Irving W; Robertson JF; Murray A; Parsy-Kowalska CB; Macdonald IK; McElveen J; Allen J; Healey GF; Thomson BJ; Ryder SJ; Holdenrieder S; Chapman CJ
PLoS One; 2014; 9(8):e103867. PubMed ID: 25093332
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
Ma Y; Qiu C; Wang B; Zhang X; Wang X; Aguilera RJ; Zhang JY
Cells; 2022 Oct; 11(20):. PubMed ID: 36291095
[TBL] [Abstract][Full Text] [Related]
17. Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
Sun Y; Gao G; Cai J; Wang Y; Qu X; He L; Liu F; Zhang Y; Lin K; Ma S; Yang X; Qian X; Zhao X
Carcinogenesis; 2013 Mar; 34(3):595-604. PubMed ID: 23188673
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody recognition of an N-terminal epitope of hnRNP L marks the risk for developing HBV-related hepatocellular carcinoma.
Yau WY; Shih HC; Tsai MH; Sheu JC; Chen CH; Chow LP
J Proteomics; 2013 Dec; 94():346-58. PubMed ID: 24125732
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.
Liu M; Zheng SJ; Chen Y; Li N; Ren PF; Dai LP; Duan ZP; Zhang JY
J Immunol Res; 2014; 2014():906532. PubMed ID: 24955377
[TBL] [Abstract][Full Text] [Related]
20. A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.
Liu M; Liu X; Ren P; Li J; Chai Y; Zheng SJ; Chen Y; Duan ZP; Li N; Zhang JY
Tumour Biol; 2014 May; 35(5):4247-56. PubMed ID: 24390614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]